Prévisions du marché des particules de type virus en Asie-Pacifique jusqu’en 2028 – Impact du COVID-19 et analyse régionale par type de produit (hépatite, cancer/VPH et maladie de Gaucher), source (levure, cellules d’insectes, plantes et autres) et application (vaccins et thérapeutique)

Le marché des particules de type virus en Asie-Pacifique devrait passer de 1 018,83 millions de dollars américains en 2021 à 1 769,02 dollars américains. millions d\'ici 2028 ; il devrait croître à un TCAC de 8,2 % de 2021 à 2028.

Divers acteurs du marché des soins de santé et organismes de recherche sont activement impliqués dans les innovations et les développements de produits. L’utilisation de particules pseudo-virales est une approche émergente utilisée dans l’industrie biopharmaceutique. Comme les particules pseudo-virales ne contiennent pas de contenu viral, elles sont plus faciles à manipuler que les composants viraux réels. Les VLP peuvent être utilisées pour faciliter l’administration de médicaments, l’imagerie, l’immunothérapie et la théragnostique. Par exemple, selon une étude publiée dans le NCBI en juin 2020, les VLP peuvent être utilisées sous forme de nanoparticules dans des applications telles que la thérapie photothermique, l\'imagerie TEP et CT, les supports d\'agents de contraste IRM, l\'imagerie optique, les vaccins contre les maladies inflammatoires et auto-immunes, l\'immunothérapie du cancer et l\'administration de médicaments à petites molécules (dans le traitement du cancer). Ainsi, ces applications potentielles des VLP devraient offrir des opportunités de croissance aux acteurs du marché au cours de la période de prévision.

Selon le rapport du Fonds monétaire international (FMI). , la croissance en Asie-Pacifique devrait stagner à zéro pour cent en 2020. Il s’agit de la pire performance de croissance depuis près de 60 ans, impliquant la crise financière mondiale (4,7 %) et la crise financière asiatique (1,3 %). Les révisions à la baisse ont été substantielles, allant de 3,5 % dans le cas de la Corée, mais ont semblé gérer la lente propagation du coronavirus en raison de la minimisation des arrêts prolongés de la production représentant 9 % en Australie, en Nouvelle-Zélande et en Thaïlande. Ces pays ont été durement touchés par la fermeture du tourisme à l’échelle mondiale et, dans le cas de l’Australie, par la baisse des prix des matières premières. La région Asie-Pacifique, où les vaccins contre le COVID-19 sont actuellement en cours de développement, comprend la Corée du Sud, la Chine, le Japon, la Thaïlande et le Vietnam. Parmi ceux-ci, la Chine dispose de 15 vaccins, l’Inde et la Corée du Sud en possèdent trois, le Japon en possède deux et la Thaïlande et le Vietnam en possèdent un. Parmi ces vaccins, il y a dix vaccins inactivés, six vaccins à sous-unités protéiques, sept vaccins à vecteur viral et six vaccins à acide nucléique. En outre, la promotion d’un vaccin sûr, équitable et efficace est une priorité absolue dans la région Asie-Pacifique. Selon le rapport de la Banque asiatique de développement, en décembre 2020, la Banque asiatique de développement (BAD) a lancé une initiative de vaccination de 9 milliards de dollars américains avec le Fonds d\'accès aux vaccins pour l\'Asie-Pacifique (APVAX) qui offrira un soutien rapide et équitable aux pays membres en développement. pays (DMC) pour acheter et livrer un vaccin efficace et sûr contre la COVID-19. Grâce à la vaccination, elle peut briser la chaîne de transmission du virus, sauver des vies et atténuer l\'impact négatif de la pandémie.

Avec le nouveau Grâce à leurs fonctionnalités et technologies, les fournisseurs peuvent attirer de nouveaux clients et étendre leur présence sur les marchés émergents. Ce facteur est susceptible de stimuler le marché des particules de type virus en Asie-Pacifique. Le marché des particules de type virus en Asie-Pacifique devrait croître à un bon TCAC au cours de la période de prévision.

Chiffre d’affaires et prévisions du marché des particules de type virus en Asie-Pacifique jusqu’en 2028 (millions de dollars américains)

Segmentation du marché des particules de type virus en Asie-Pacifique

Marché des particules de type virus en Asie-Pacifique - Par type de produit

Hépatite
Cancer/HPV
Maladie de Gaucher

Marché des particules de type virus en Asie-Pacifique - Par source

Levure
Cellule d\'insecte
Usine
Autres

Marché des particules de type virus en Asie-Pacifique - Par Application

Vaccins
Thérapeutiques

Marché des particules de type virus en Asie-Pacifique - Par Pays

Marché des particules de type viral en Asie-Pacifique - Entreprises mentionnées

Merck & Co., Inc. & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; ; &nb sp ;
GlaxoSmithKline plc.
Pfizer Inc. ; &nb sp ; ;
Sanofi ; ;
< span>Sérum Institute of India Pvt. Ltd.
BHARAT BIOTECH ; &nb sp ;
LG Chem ; ;
Wantai BioPharm

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Virus-like Particles Market – By Product Type

1.3.2 Asia Pacific Virus-like Particles Market – By Source

1.3.3 Asia Pacific Virus-like Particles Market – By Application

1.3.4 Asia Pacific Virus-like Particles Market – By Country

2. Asia Pacific Virus-like Particles Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Virus-like Particles Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Infectious Viral Diseases

5.1.2 Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2 Market Restraints

5.2.1 Reach of Alternative Technologies for Viral Vaccine Production

5.3 Market Opportunities

5.3.1 Growing Potential Applications in Therapeutics and Diagnostics

5.4 Future Trends

5.4.1 Steady Demand for Innovative and Effective Products

5.5 Impact Analysis

6. Asia Pacific Virus-like Particles Market Analysis

6.1 Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7. Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1 Overview

7.2 Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer/ Human Papillomavirus (HPV)

7.4.1 Overview

7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5 Gaucher Disease

7.5.1 Overview

7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Virus-like Particles Market Analysis – By Source

8.1 Overview

8.2 Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3 Yeast

8.3.1 Overview

8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4 Plant

8.4.1 Overview

8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5 Insect Cell

8.5.1 Overview

8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Virus-like Particles Market Analysis – By Application

9.1 Overview

9.2 Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4 Therapeutics

9.4.1 Overview

9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Virus-like Particles Market – Country Analysis

10.1 Overview

10.1.1 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1 Impact Assessment of COVID-19 Pandemic

12. Asia Pacific Virus-like Particles Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Merck & Co., Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 GlaxoSmithKline plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sanofi

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Wantai BioPharm

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Serum Institute of India Pvt. Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BHARAT BIOTECH

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 LG Chem

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1. Asia Pacific Virus-like particles Market Segmentation

Figure 2. Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3. Asia Pacific Virus-like Particles Market Overview

Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5. India to Show Significant Growth during Forecast Period

Figure 6. Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10. Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000